Friday, January 30, 2009

Comment on the firing of Mark Dybul as head of OGAC (Office of Global AIDS Coordinator) . It is a shame the way Mark was handled. I am attaching a NY Times article covering this. Mark is back in my office until his retirement. NY Times article:: The abrupt departure of the State Department’s global AIDS coordinator has led to debate over who should run what may be President Bush’s greatest legacy: his commitment of billions of dollars to fighting AIDS overseas. The position — U.S. Global AIDS Coordinator and director of the President’s Emergency Plan for AIDS Relief, which is known as Pepfar — is a State Department post with ambassador’s rank that had been held by Dr. Mark R. Dybul, a Bush administration appointee. On Jan. 9, Dr. Dybul circulated a memo saying he had been asked by President Obama’s transition team to stay on the job temporarily. But on Jan. 22, one day after Hillary Clinton was confirmed as secretary of state, her staff announced that Dr. Dybul had resigned. No reason was given, but he was reported to have packed up his office and said an emotional goodbye to his staff that afternoon. Dr. Dybul did not return phone messages, but he has told friends that he does not even know on whose orders he was dismissed. “He deserved better,” said a friend who asked not to be identified for fear of jeopardizing his government job. “He didn’t want to stay, but he was asked to.” The ambassador disburses Pepfar’s funds; Congress authorized $15 billion over five years in 2003, and the fund has since paid for AIDS drugs for about two million people, mostly in Africa. Last year, after a bitter fight between liberal and conservative lawmakers over what the money could be spent on, the fund was renewed as part of a law authorizing $48 billion over five years for combating AIDS, tuberculosis and malaria. The question of who should run the program seems to be a legacy of that fight. Several names have been discussed as possible candidates, but AIDS activists say they know of no one who has been seriously vetted for the job by the Obama transition team since November. A day after Dr. Dybul’s resignation, word began to circulate among AIDS activists that the job had been offered to Dr. Eric Goosby, the director of AIDS policy in Bill Clinton’s administration, who now runs a San Francisco foundation devoted to fighting AIDS. According to a member of an anti-AIDS group speaking on the condition of anonymity, Senator John Kerry approached Mrs. Clinton, seeking the job for Dr. Jim Yong Kim, a Harvard medical school professor and former World Health Organization AIDS chief, and was told that she had offered it to Dr. Goosby. Through a spokesman, Dr. Goosby declined to confirm or deny that he had been offered the job, and Dr. Kim did not return phone calls seeking comment. Senator Kerry’s spokesman said he would not discuss the senator’s personal conversations with Mrs. Clinton. Both men had been discussed as possible candidates, along with Dr. Nils Daulaire, president of the Global Health Council; Dr. Wafaa El-Sadr, an epidemiologist at the Columbia School of Public Health; and Warren W. Buckingham III, Pepfar’s director in Kenya, who is openly gay and taking AIDS drugs himself. Dr. Daulaire declined to be interviewed, Dr. El-Sadr said she had not heard that her name was among those being discussed, and Mr. Buckingham said he knew his name had been suggested by others but had not lobbied for the job and had not been contacted by either the Obama or Clinton teams. The abruptness of Dr. Dybul’s departure and the secrecy of the process to replace him has upset some AIDS policy specialists. On Monday, a coalition of 68 anti-AIDS groups sent a letter to Mrs. Clinton asking her not to fill Mr. Dybul’s post immediately but to convene a committee to identify top candidates and get many viewpoints, including theirs. One of its authors, Brian Hennessey of the Vineeta Foundation, expressed his irritation at how the request was ignored. “Goosby is not bad,” he said. “There are plenty of people who want Goosby — but they’ll be damned if the job is filled this way. This isn’t the truth-in-advertising of the Obama campaign.” Dr. Dybul’s departure was both celebrated and condemned. Jodi Jacobson, a former head of the Center for Health and Gender Equity, which wants financing for all aspects of women’s reproductive health, including abortion, wrote a blog post titled “Dybul Out: Thank You Hillary!!!” It argued that he had worked too closely with the far right, and she accused him of lobbying to please the Roman Catholic Church by letting its relief groups opt out of distributing condoms. Michael Gerson, a former Bush speechwriter and Washington Post columnist, shot back that “blogging extremists” like Ms. Jacobson had lied about Dr. Dybul’s record and that his firing had left an important program without a leader. At the heart of the debate was the difficult bipartisan compromise behind Mr. Bush’s AIDS plan. It is the darling of two groups that normally oppose each other: foreign policy liberals who want to help Africa and evangelical Christians who support mission hospitals there. Dr. Dybul was straddling some personal fences too: he was one of the Bush administration’s few openly gay officials, a doctor who had treated AIDS patients in San Francisco and Africa, and he had donated to Democratic causes. His only predecessor, Randall L. Tobias, a former pharmaceutical executive, was promoted within the State Department, then ousted in the D.C. Madam scandal after acknowledging he had received escort-service massages — a development that led to derision over the fund’s abstinence policies. Mr. Tobias and Dr. Dybul surprised many with two early decisions that activists had expected fights over: Pepfar has paid for millions of condoms, and it buys cheap generic drugs from India, despite the pharmaceutical lobby’s opposition. But conservatives in Congress imposed other restrictions: one-third of the money spent on prevention had to be used for teaching abstinence until marriage. Groups getting funds, including those helping prostitutes, had to sign a pledge condemning prostitution. And no money could be spent on clean needles for drug addicts. These issues were divisive not just for liberals and conservatives, but also between liberals. For example, some feminists think women needing money have a right to engage in prostitution, while others oppose it, saying it contributes to human trafficking and child rape. In separate studies, the Government Accountability Office and the Institute of Medicine both found that the abstinence earmark unnecessarily tied the hands of fund recipients, especially in countries where AIDS was concentrated among drug users and prostitutes. Dr. Dybul defended the teaching of abstinence, especially to young children, because it can be effective among deeply religious rural Africans. And he argued that countries could get funds for prohibited uses, like clean needles, from other donors like the Global Fund for AIDS, Tuberculosis and Malaria or European countries. Although the restrictions have been criticized, no one has presented scientific evidence that they cost any lives. And although there was grumbling in 2003 when the Bush administration created its own AIDS program rather than simply contributing to the Global Fund, Rajat Gupta, chairman of the Global Fund’s board, said Thursday in Davos that Pepfar was “one of the truly great contributions of the last administration.” Jan. 30 – Feb. 20 – Stock market continues to crash with DOW in the 7500 range. Thus far I have lost on paper more than $1 million of my wealth. Tom Daschle had to drop out of running for the Secretary of HHS because of concern over unpaid taxes for private car and driver that was loaned to him for 3 years without charge by a friend. He did not claim it as taxable income, which it is. Also, he made $5 million on influence peddling (access to people in government) since he stepped down as Senator. Too bad since he is a very good person and would have made a great Secretary. I still think that I would fit for that job, but I really do not want to leave what I am doing and besides, no one in the administration has asked me. They apparently only would want me for NIH Director and I do not want that at all.